Glutathione
γ-L-glutamyl-L-cysteinylglycine, an endogenous tripeptide antioxidant
Antioxidant research focused on redox balance, oxidative stress, and cellular detoxification pathways.
Route
Oral, IV and other routes exist clinically/research-wise
Common format
1,500 mg vial
Research focus
oxidative stress
Evidence level
Limited Human Evidence
Typical cycle
4–8 weeks
LongevityGlutathione in 30 seconds
Atlas Fast ReadWhat it is
γ-L-glutamyl-L-cysteinylglycine, an endogenous tripeptide antioxidant
Why people care
Antioxidant research focused on redox balance, oxidative stress, and cellular detoxification pathways.
Human evidence
Limited Human Evidence — Human interventional or clinical data exist, but studies are small, early-phase, mixed, indirect, route-specific, or not confirmatory.
Biggest misconception
Key gaps include larger independent trials, clearer dose-response data, long-term safety, clinically meaningful endpoints, and evidence that findings generalize beyond the narrow populations or routes already studied.
Bottom line
Glutathione has a real human signal or documented human pharmacology, but evidence is too small, mixed, route-specific, or indication-specific to justify broad claims.
Overview
What is Glutathione?
Glutathione is γ-L-glutamyl-L-cysteinylglycine, an endogenous tripeptide antioxidant. Antioxidant research focused on redox balance, oxidative stress, and cellular detoxification pathways.
Glutathione was identified as a biological sulfur-containing compound in the early 20th century and later established as a central intracellular antioxidant. Injectable use predates modern peptide-hacking culture and spans medical and wellness settings.
Mechanism
How it works
Acts as a major intracellular redox buffer and substrate for glutathione peroxidases, helping reduce peroxides and maintain protein thiol status. It also participates in xenobiotic conjugation through glutathione-S-transferases.
Research areas
Evidence
What does the evidence actually say?
Human interventional or clinical data exist, but studies are small, early-phase, mixed, indirect, route-specific, or not confirmatory.
Preclinical Evidence
Limited Human Evidence
Strong Human Evidence
Human evidence
Preclinical evidence
Knowledge gaps
Protocol
Research protocol
Dose
Frequency
Timing
Route
Cycle length
Reconstitution
Storage
Monitoring
Protocols vary widely between sources. Investigational compounds are not approved therapies, and approved products should follow their official labeling. Nothing here is medical advice.
Safety
Safety, side effects, and precautions
Side effects
Contraindications
Interactions
Stacks
Common stacks
Glutathione + NAD+
Common wellness-clinic pairing intended to combine redox support with NAD metabolism.
No strong evidence that the combination improves longevity or performance.
Questions
FAQ
References
Sources
Atlas
The Atlas verdict
Glutathione has a real human signal or documented human pharmacology, but evidence is too small, mixed, route-specific, or indication-specific to justify broad claims. The most defensible use of the literature is to separate what has actually been measured in people from what is still extrapolated from mechanism or animal work.
More in Longevity
Longevity
Cortagen
Peptide bioregulator research focused on neuroregeneration, brain aging, and cognitive function.
Read guideLongevity
Epitalon
Pineal-derived tetrapeptide research exploring telomerase activity, circadian biology, and healthy aging.
Read guideLongevity
FOXO4-DRI
Experimental senolytic peptide research investigating selective removal of senescent cells.
Read guide